NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $557,000 | -4.6% | 6,348 | -4.9% | 0.10% | -2.9% |
Q4 2021 | $584,000 | +6.0% | 6,674 | -1.0% | 0.10% | -1.0% |
Q3 2021 | $551,000 | -12.3% | 6,740 | -2.0% | 0.10% | -18.0% |
Q2 2021 | $628,000 | +4.1% | 6,881 | -2.5% | 0.13% | -8.6% |
Q1 2021 | $603,000 | -10.1% | 7,060 | +0.9% | 0.14% | -13.0% |
Q4 2020 | $671,000 | +10.4% | 6,999 | +0.1% | 0.16% | -4.7% |
Q3 2020 | $608,000 | -1.1% | 6,994 | -0.6% | 0.17% | -13.3% |
Q2 2020 | $615,000 | +3.4% | 7,036 | -2.5% | 0.20% | -17.4% |
Q1 2020 | $595,000 | -14.6% | 7,216 | -1.9% | 0.24% | +0.4% |
Q4 2019 | $697,000 | +7.7% | 7,358 | 0.0% | 0.24% | +4.4% |
Q3 2019 | $647,000 | -1.7% | 7,358 | +4.4% | 0.22% | -28.6% |
Q2 2019 | $658,000 | -8.5% | 7,047 | -5.7% | 0.32% | -10.8% |
Q1 2019 | $719,000 | +10.8% | 7,474 | -1.2% | 0.35% | -11.5% |
Q4 2018 | $649,000 | – | 7,562 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |